CRON FY 2021 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena

CRONCronos Group Inc.

$983M

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$65M+38.2% YoY

Gross Profit

-$18M-27.3% margin

Operating Income

-$292M-452.2% margin

Net Income

-$396M-613.5% margin

EPS (Diluted)

$-1.07

Cash Flow

Operating Cash Flow

-$154M

Free Cash Flow

-$166M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$63M

Stockholders' Equity

$1.3B

Cash & Equivalents

$887M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$65M	$47M	+38.2%
Gross Profit	-$18M	-$26M	+31.9%
Operating Income	-$292M	-$219M	-33.1%
Net Income	-$396M	-$73M	-441.6%